Spectral Diagnostics Incorporated Company Profile

04:49 EDT 22nd October 2016 | BioPortfolio

Spectral Diagnostics Inc. remains dedicated to being the leader in the research, development and commercialization of decision point diagnostics. Our commitment to the development of new and novel rapid tests, such as the patented Cardiac Panel™, reagents and membranes, distinguishes the Company's approach to the diagnosis of cardiac and other serious conditions at the medical decision point. Spectral is a Canadian publicly traded company incorporated in 1991 with operations in Canada, the United States and Europe. Spectral's products are available worldwide


111 Pencader Drive
United States of America


Phone: 302 456 6789
Fax: 416 626 7383

News Articles [620 Associated News Articles listed on BioPortfolio]

University Medical Center Utrecht expands diagnostic capabilities with Philips IQon spectral CT system

Royal Philips announced the installation of its IQon Spectral CT, the industry’s first spectral detector-based Computed Tomography (CT) at the University Medical Center Utrecht (UMC Utrecht). The Ph...

Bio-Rad KnowItAll 2017 spectroscopy software

Bio-Rad Laboratories has announced the release of its KnowItAll 2017 spectroscopy software and databases. The release offers an additional 976,000 reference spectra in the KnowItAll Spectral Library, ...

Spectral imaging technologies in microscopy: an interview with Alex Cooper

Spectral imaging encompasses two types of light control when using a microscope. Conventional microscopes use fluorescence excitation and emission filters, matched to fluorescent probes, in order to v...

Spectral Medical completes enrollment for EUPHRATES clinical trial

TORONTO, ON – Spectral Medical Inc. reports that it has completed patient enrollment for its pivotal Phase 3 EUPHRATES clinical trial. The clinical trial is intended to demonstrate the safety an...

BRIEF-Spectral Medical Q1 revenue $1.5 million

* Spectral Medical Inc says revenue for three months ended march 31, 2016 was $1.5 million compared to $877,000 for same three month period last year Source text for Eikon: Further company coverage:...

BRIEF-Spectral Medical completes of enrolment for Euphrates trial

* Spectral Medical announces completion of enrolment for its pivotal Euphrates clinical trial Source text for Eikon: Further company coverage:

BRIEF-Spectral Medical says FDA accepts its expanded access protocol for toraymyxin

* FDA accepts Spectral's expanded access protocol for toraymyxin Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Spectral Responds to Recent Trading Activity

TORONTO, ONTARIO -- (Marketwired) -- 09/20/16 -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT) (OTCQX: EDTXF), at the request of IIROC on behalf of the Toronto Stock Exchange, confi...

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]


Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [867 Associated PubMed Articles listed on BioPortfolio]

Progress and potential of RAS mutation detection for diagnostics and companion diagnostics.

The importance of RAS mutation in carcinogenesis is established, and knowledge of an individual cancer's mutation status is important for optimal treatment.

A multichannel smartphone optical biosensor for high-throughput point-of-care diagnostics.

Current reported smartphone spectrometers are only used to monitor or measure one sample at a time. For the first time, we demonstrate a multichannel smartphone spectrometer (MSS) as an optical biosen...

Experimental demonstration of an adaptive architecture for direct spectral imaging classification.

Spectral imaging is a powerful tool for providing in situ material classification across a spatial scene. Typically, spectral imaging analyses are interested in classification, though often the classi...

Next-Generation Sequencing in Cancer Diagnostics.

This commentary highlights the article by Misyura et al that underscores the use of next-generation sequencing platforms for detection and verification of somatic variants.

Spectral Quantification for High-Resolution MR Spectroscopic Imaging with Spatiospectral Constraints.

Spectral quantification is a key step for magnetic resonance spectroscopic imaging (MRSI). However, obtaining reliable spectral parameters for practical applications is challenging due to low signal-t...

Clinical Trials [190 Associated Clinical Trials listed on BioPortfolio]

Spectral Diagnosis of Cutaneous Malignancy

The goal of this clinical research study is to evaluate the use of an imaging technology called spectral diagnosis. Researchers want to find out if a special spectral-diagnosis probe can ...

Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes

This study is designed to evaluate and compare in-tissue performance of OCT scans on the new Optos P200TE, versus the predicate Optos Spectral OCT/SLO device.

Ocular Imaging With Spectral Domain Optical Coherence Tomography

The purpose of this study is to analyze macular retinal thickness and macular volume using the spectral domain - optical coherence tomography (SD-OCT) in normal eyes and in eyes with vario...

Spectral Dynamic Imaging of Cognitive Functions in Epileptic Patients Explored Stereoelectroencephalography

This prospective research aims to develop the use of Spectral Imaging in addition Dynamics of cortical electrical stimulation to identify major anatomical and functional networks in epilep...

Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies

The purpose of this study is to compare the newly released Spectral OCT/SLO (OTI, Toronto, Canada) with the Zeiss Stratus OCT (Carl-Zeiss Meditec, Dublin, CA) with regards to the quality o...

Companies [904 Associated Companies listed on BioPortfolio]

Spectral Diagnostics Incorporated

Spectral Diagnostics Inc. remains dedicated to being the leader in the research, development and commercialization of decision point diagnostics. Our commitment to the development of new and novel ra...

Spectral Diagnostics Inc.

Spectral Imaging Inc

Applied Spectral Imaging (ASI) is a leading provider of cytogenetics systems to prestigious clinical and research labs all over the world. Its CytoLabView suite offers a complete solution for all imag...

Applied Spectral Imaging (ASI)

Applied Spectral Imaging (ASI) makes patient care better through advanced biomedical imaging.

Spectral Genomics, Inc

Spectral Genomics BAC clone arrays provide a complete view of the genome allowing researchers to view the loci of chromosomal aberrations. The company has enabled this capability for the Human Genome ...

More Information about "Spectral Diagnostics Incorporated" on BioPortfolio

We have published hundreds of Spectral Diagnostics Incorporated news stories on BioPortfolio along with dozens of Spectral Diagnostics Incorporated Clinical Trials and PubMed Articles about Spectral Diagnostics Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Spectral Diagnostics Incorporated Companies in our database. You can also find out about relevant Spectral Diagnostics Incorporated Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record